Department of Pharmaceutical Sciences, University of Florence, Florence, Italy.
J Liposome Res. 2010 Dec;20(4):315-22. doi: 10.3109/08982100903544169. Epub 2010 Jan 28.
A combined strategy, based on cyclodextrin complexation and loading in liposomes, has been investigated to develop a new delivery system with improved therapeutic activity of the local anesthetic, prilocaine (PRL). In order to evaluate the actual effectiveness and advantages of this approach compared to the traditional drug-in-liposome one, four different liposomal formulations were prepared: (1) liposomes loaded with PRL base as complex with hydroxypropyl-β-cyclodextrin (HP CD) in the aqueous phase; (2) liposomes loaded with PRL hydrochloride in the aqueous phase; (3) liposomes loaded with PRL base in the lipophilic phase; and (4) "double-loaded" liposomes, containing free PRL base in the membrane bilayer and its HP CD complex in the aqueous compartment. All batches were characterized for particle size, charge, deformability, and entrapment efficiency from using, respectively, light scattering, extrusion, and dialysis techniques, while the anesthetic effect was evaluated in vivo on Guinea pigs, according to the test of dorsal muscle contraction. All drug liposomal dispersions showed enhanced analgesic duration with respect to the corresponding aqueous solutions, but significant differences were observed between the different formulations. In particular, cyclodextrin complexation not only allowed an efficient encapsulation of PRL base in the aqueous vesicle core, but also increased the anesthetic effect duration and reduced the initial lag time, in comparison with the corresponding formulations containing, respectively, free PRL in the lipophilic phase or PRL hydrochloride in the aqueous vesicle core. The technique of double loading was the most effective, giving rise to the shortest onset time and longest duration of anesthetic effect.
一种基于环糊精络合和脂质体装载的联合策略已被研究用于开发一种新的递药系统,以提高局部麻醉药普鲁卡因(PRL)的治疗活性。为了评估与传统的药物载入脂质体方法相比,这种方法的实际效果和优势,我们制备了四种不同的脂质体制剂:(1)在水相中负载 PRl 碱基与羟丙基-β-环糊精(HP CD)复合物的载药脂质体;(2)在水相中负载 PRl 盐酸盐的载药脂质体;(3)在亲脂相中负载 PRl 碱基的载药脂质体;以及(4)“双重负载”脂质体,在膜双层中含有游离的 PRl 碱基及其在水相中的 HP CD 复合物。分别使用光散射、挤压和透析技术对所有批次的粒径、电荷、变形性和包封效率进行了表征,同时根据背部肌肉收缩试验在豚鼠体内评估了麻醉效果。与相应的水溶液相比,所有载药脂质体分散体均显示出增强的镇痛持续时间,但不同制剂之间观察到显著差异。特别是,环糊精络合不仅允许 PRl 碱基在水囊泡核心中得到有效包封,而且与分别在亲脂相中含有游离 PRl 或在水囊泡核心中含有 PRl 盐酸盐的相应制剂相比,还延长了麻醉效果的持续时间并减少了初始滞后时间。双重负载技术最为有效,导致起效时间最短,麻醉效果持续时间最长。